Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); AMR101, Lovaza and LDL at ACC: Does (Particle) Size Matter?
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Price: $14.09 +0.21%
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
6 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN), PT $11.
Canaccord analyst says, "Reiterate rating an PT on high chance of ANCHOR success, AMR101 commercial potential - AMR101 is AMRN’s purified EPA omega-3 drug for high triglycerides. We think AMRN may submit the AMR101 NDA for very high triglycerides in Q3/11 and get approval in H1/12. Our $11 target is based on a
pNPV analysis."
"ANCHOR data on track for late April/early May. We believe top-line ANCHOR data will be released by early May. The last patient trial visit occurred in mid-March."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $8.44 yesterday.
Canaccord analyst says, "Reiterate rating an PT on high chance of ANCHOR success, AMR101 commercial potential - AMR101 is AMRN’s purified EPA omega-3 drug for high triglycerides. We think AMRN may submit the AMR101 NDA for very high triglycerides in Q3/11 and get approval in H1/12. Our $11 target is based on a
pNPV analysis."
"ANCHOR data on track for late April/early May. We believe top-line ANCHOR data will be released by early May. The last patient trial visit occurred in mid-March."
For more ratings news on Amarin Corporation click here and for the rating history of Amarin Corporation click here.
Shares of Amarin Corporation closed at $8.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
- UBS Downgrades Converge ICT Solutions Inc (CNVRG:PM) to Neutral
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
